Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Sirolimus-eluting stents: opposite in vitro effects on the clonogenic cell potential on a long-term exposure
This is not the latest version of this item. The latest version can be found here.

Sirolimus-eluting stents: opposite in vitro effects on the clonogenic cell potential on a long-term exposure

Thumbnail Image
Download
Name

27554-1057574-1-PB.pdf

Description
Published version
Size

1.81 MB

Format

Adobe PDF

Checksum (MD5)

4cd06cdc1f2d5ace481dbe3f22f81e9a

sword-2021-09-10T15:04:10.original.xml (130 B)
Original SWORD entry document
Author(s)
Vasuri, Francesco
•
Degiovanni, Alessio
•
Gargiulo, Mauro
•
Thilly, William G
•
Gostjeva, Elena V
•
Pasquinelli, Gianandrea
•
Fittipaldi, Silvia
Date Issued
2020
Journal
Oncotarget
Publisher
Impact Journals, LLC
Version
Final published version
Abstract
Copyright: © Vasuri et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. We evaluated the long-term effects of sirolimus on three different cell in vitro models, cultured in physiological conditions mimicking sirolimus-eluted stent, in order to clarify the effectiveness of sirolimus in blocking cell proliferation and survival. Three cells lines (WPMY-1 myofibroblasts, HT-29 colorectal adenocarcinoma, and U2OS osteosarcoma) were selected and growth in 10 ml of Minimum Essential Medium for 5 weeks with serial dilutions of sirolimus. The number of colonies and the number of cells per colony were counted. As main result, the number of WPMY-1 surviving colonies increased in a dose-dependent manner when treated with sirolimus (p = 0.0011), while the number of U2OS colonies progressively decreased (p = 0.0011). The clonal capacity of HT-29 was not modified by the exposure to sirolimus (p = 0.6679). In conclusion sirolimus showed the well-known cytostatic effect, but with an effect on clonogenic potential different among the different cell types. In the practice, the plaque typology and composition may influence the response to sirolimus and thus the effectiveness of eluted stent.
Terms of Use
Creative Commons Attribution 3.0 unported license
https://creativecommons.org/licenses/by/3.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/133598
DOI of Published Version
10.18632/ONCOTARGET.27554
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.